Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial to Explore Benefit and Tolerability of IQP-AS-105 (Xaludicin®) in Subjects With Increased Susceptibility to Upper Respiratory Tract Infections

NCT01964885 is registered in ClinicalTrials.gov with InQpharm Group as lead sponsor.

NCT NCT01964885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01964885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial to Explore Benefit and Tolerability of IQP-AS-105 (Xaludicin®) in Subjects With Increased Susceptibility to Upper Respiratory Tract Infections
Lead sponsor
InQpharm Group
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2013
Completion date
May 31, 2014
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, upper respiratory tract infections